These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7808670)

  • 1. [Effectiveness of quarterly assessment of CEA, TPA and GICA serum levels in gastric and colorectal carcinomas: Prospective study of 174 patients undergoing radical surgery].
    Barillari P; Ricci M; Broglia S; Manetti G; Cerasi A; Cesareo S; Calcaterra D; Cioè I; Caronna R; Sammartino P
    Minerva Chir; 1994 Oct; 49(10):953-61. PubMed ID: 7808670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
    Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
    J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences.
    Barillari P; Sammartino P; Cardi M; Ricci M; Gozzo P; Cesareo S; Cerasi A
    Aust N Z J Surg; 1991 Sep; 61(9):675-80. PubMed ID: 1877936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
    Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
    J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer.
    Wolf RF; Cohen AM
    J Am Coll Surg; 1997 Jul; 185(1):60-4. PubMed ID: 9208962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
    Grotowski M
    Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CEA, GICA, TPA, fibrinopeptide-A, gamma-GT and gastric cancer. A contribution to the rationalization of a combined assay].
    Abbasciano V; Graziano L; Arcudi D; Tassinari D; Nielsen I; Sartori S
    Recenti Prog Med; 1991 Oct; 82(10):517-9. PubMed ID: 1684676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
    Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEA, TPA, CA 19-9, SCC and CYFRA at diagnosis and in the follow-up of anal canal tumors.
    Indinnimeo M; Reale MG; Cicchini C; Stazi A; Fiori E; Izzo P
    Int Surg; 1997; 82(3):275-9. PubMed ID: 9372374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of four tumor markers (CEA, TPA, CA50 and CA72-4) in colorectal cancer].
    Koizumi F; Odagiri H; Fujimoto H; Kawamura T; Ishimori A
    Rinsho Byori; 1992 May; 40(5):523-8. PubMed ID: 1507478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer].
    Nishida O; Shiroto H; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J
    Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
    Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
    Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastrointestinal cancer].
    Takahashi Y
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1275-9. PubMed ID: 15332558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
    Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
    Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
    Engarås B; Kewenter J; Nilsson O; Wedel H; Hafström L
    Eur J Surg Oncol; 2001 Feb; 27(1):43-8. PubMed ID: 11237491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of follow-up in the management of recurrent colorectal cancer.
    Camuñas J; Enriquez JM; Devesa JM; Morales V; Millan I
    Eur J Surg Oncol; 1991 Oct; 17(5):530-5. PubMed ID: 1936302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.